April 10 — 13, 2026 San Juan, PR

Booth #709

Spotlight Session

4 Abstracts

SGO 2026 Annual Meeting on Women’s Cancer

Join Tempus at the SGO 2026 Annual Meeting on Women’s Cancer as we showcase our latest clinical research. Visit our booth to learn more about our latest cutting-edge, AI-powered technology and new product offerings all designed to drive more informed, personalized care across the patient journey.

Schedule a meeting with us
Abstracts
April 12, 2026
Time
4:00 pm - 4:45 pm
Presenters
Jordyn Silverstein, et al.

Genomic and Transcriptomic Analysis To Uncover Potential Biomarkers of Response and Primary Resistance to Mirvetuximab Soravtansine in Patients with Ovarian Cancer

Time
TBD
Presenters
Ursula A. Matulonis, et al.

MUC16 in ovarian cancer: high, stable expression across histologic subtypes, disease stages, and platinum sensitivity status supports antibody-drug conjugate development

Time
11:30am-12:00pm
Presenters
Kathleen N. Moore, et al.

High and stable MUC16 expression in endometrial cancer highlights potential for targeted antibody-drug conjugate development

Time
TBD
Presenters
David M. O'Malley, et al.

MUC16 As a Therapeutic Target: Advancing Antibody-Drug Conjugates for Ovarian Cancer Treatment

Spotlight Session
April 12, 2026
Time
11:30am - 12:00pm
Presenters
Katherine Moore

Group 9: Targeted Tactics and Therapies

Schedule a meeting with us

We'll be in touch shortly.